Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling Participant Complaints and Concerns

Posted on By

Standard Operating Procedure for Addressing Participant Feedback and Issues in Clinical Research

Purpose

This SOP outlines the procedures for receiving, investigating, and resolving participant complaints and concerns in clinical trials and clinical studies. The goal is to ensure participants feel heard and supported, maintain trust in the research process, and promote ethical and high-quality studies.

Scope

This SOP applies to all personnel involved in clinical trials and clinical studies, including principal investigators, clinical research coordinators, and other study team members.

Responsibilities

  • Principal Investigator (PI): Oversees the complaint resolution process and ensures appropriate follow-up with participants.
  • Clinical Research Coordinators: Serve as primary points of contact for participant complaints and concerns, and facilitate resolution.
  • Study Team Members: Escalate participant complaints and concerns to the PI or study coordinator for resolution as needed.
See also  SOP for Interim Analysis and Data Monitoring Committees

Procedure

  • Receiving Complaints and Concerns:
    • Provide participants with clear channels for submitting complaints and concerns (e.g., phone, email, in-person meetings).
    • Acknowledge receipt of complaints and concerns promptly, ideally within 24 hours.
  • Investigation and Resolution:
    • Conduct a thorough investigation of participant complaints and concerns, gathering relevant information and consulting with involved parties.
    • Maintain participant confidentiality during the investigation and resolution process.
    • Develop and implement a plan to resolve the issue, ensuring participant satisfaction and compliance with study protocols and regulations.
    • Communicate the resolution plan to the participant and
follow up to ensure their concerns have been addressed.
  • Documentation:
    • Document all participant complaints and concerns, including details of the complaint, the investigation process, and the resolution.
    • Maintain records of complaints and resolutions for auditing and regulatory compliance purposes.
  • Training and Education:
    • Provide training to study personnel on how to handle participant complaints and concerns with empathy and professionalism.
    • Offer ongoing education on best practices for addressing participant feedback and issues.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator

    Documents

    • Complaint and concern logs
    • Investigation and resolution reports
    • Follow-up communication records
    • Training materials

    References

    • Institutional policies for handling complaints and concerns
    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)

    SOP Version

    Version: 1.0

    See also  SOP for Randomization and Allocation Procedures
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Handling Exclusion and Inclusion Criteria
    Next Post: SOP for Safety Monitoring and Reporting

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version